HN
Hemal Naranbhai Patel
About Hemal Naranbhai Patel
Data last updated:
Hemal Naranbhai Patel is a Director at Apister Lifesciences Private Limited (since 2025), Director at Maharshi Pharma Chem Private Limited (since 2022) and Director at Genpep Pharmaceuticals Private Limited (since 2024), and holds 5 more current directorships. The companies operate in Pharma, Paper and Wood. The 3 current companies with reported revenue have a combined latest revenue of ₹145 Cr; the largest is Apister Lifesciences Private Limited at ₹73.56 Cr (FY 2025). Earlier, Hemal Naranbhai Patel was a Director at Vidman Pharmaceuticals Private Limited (2017–2019) and Director at Brichem Sciences Private Limited (2017–2019) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apister Lifesciences Private Limited U24304GJ2017PTC097161 | Director | 01 Jan 2025 | 2017 | ₹73.56 Cr (FY 2025) | Active |
 Maharshi Pharma Chem Private Limited U24230GJ1998PTC034706 | Director | 03 Mar 2022 | 1998 | ₹68.24 Cr (FY 2023) | Active |
 Genpep Pharmaceuticals Private Limited U24299GJ2021PTC122976 | Director | 03 Feb 2024 | 2021 | ₹3.68 Cr (FY 2025) | Active |
| Solaris Pharmatech Llp ACB-9723 | Designated Partner | 30 Sep 2025 | 2023 | Active | |
| Govind Biosciences Private Limited U21004GJ2025PTC159639 | Director | 28 Feb 2025 | 2025 | Active | |
| Amigen Biosciences Private Limited U21001GJ2024PTC151749 | Director | 23 Jul 2024 | 2024 | Active | |
| Vidman Healthcare Private Limited U21002GJ2024PTC150969 | Director | 25 Apr 2024 | 2024 | Active | |
| Oxavant Pharma Llp ACC-9331 | Designated Partner | 11 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vidman Pharmaceuticals Private Limited U24110GJ2017PTC098605 | Director | 07 Aug 2017 | 2017 | ₹3.52 Cr (FY 2024) | Active |
 Brichem Sciences Private Limited U24304GJ2016PTC094569 | Director | 03 Aug 2017 | 2016 | ₹91.35 Cr (FY 2025) | Active |
| Milikem Pharmaceuticals Private Limited U24232MH2007PTC169739 | Director | 07 Apr 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hemal Naranbhai Patel
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemal Naranbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemal Naranbhai Patel
Hemal Naranbhai Patel currently holds 8 directorships: Apister Lifesciences Private Limited (Director, since 01 Jan 2025, revenue ₹73.56 Cr (FY 2025)); Maharshi Pharma Chem Private Limited (Director, since 03 Mar 2022, revenue ₹68.24 Cr (FY 2023)); Genpep Pharmaceuticals Private Limited (Director, since 03 Feb 2024, revenue ₹3.68 Cr (FY 2025)); Solaris Pharmatech Llp (Designated Partner, since 30 Sep 2025); Govind Biosciences Private Limited (Director, since 28 Feb 2025); and 3 more.
Hemal Naranbhai Patel was first appointed on 07 Apr 2007 as Director at Milikem Pharmaceuticals Private Limited. The most recent appointment on record is 30 Sep 2025 at Solaris Pharmatech Llp.
The 3 current companies of Hemal Naranbhai Patel that report revenue have a combined latest revenue of ₹145 Cr: Apister Lifesciences Private Limited ₹73.56 Cr (FY 2025); Maharshi Pharma Chem Private Limited ₹68.24 Cr (FY 2023); Genpep Pharmaceuticals Private Limited ₹3.68 Cr (FY 2025).
Hemal Naranbhai Patel held 3 earlier board appointments: Vidman Pharmaceuticals Private Limited (Director, 07 Aug 2017 to 23 Mar 2019); Brichem Sciences Private Limited (Director, 03 Aug 2017 to 23 Mar 2019); Milikem Pharmaceuticals Private Limited (Director, from 07 Apr 2007).
The current boards of Hemal Naranbhai Patel's companies include Ami Hemal Patel (Apister Lifesciences Private Limited), Aashay Jayantilal Patel (Maharshi Pharma Chem Private Limited), Mitulkumar Sureshbhai Zala (Maharshi Pharma Chem Private Limited), Paragkumar Gunvantlal Bhavsar (Maharshi Pharma Chem Private Limited), Adinath Murlidhar Jain (Genpep Pharmaceuticals Private Limited), Mahesh Vasant Sonar (Genpep Pharmaceuticals Private Limited), among others.